openPR Logo
Press release

Isabellenhüttes IVT-S measures current in the Fraunhofer development platform foxBMS

08-24-2017 03:43 PM CET | Industry, Real Estate & Construction

Press release from: Isabellenhütte Heusler GmbH & Co. KG

/ PR Agency: Wassenberg Public Relations für Industrie & Technologie GmbH
IVT-S measures current in the Fraunhofer development platform foxBMS

IVT-S measures current in the Fraunhofer development platform foxBMS

The Fraunhofer Institute for Integrated Systems and Device Technology (IISB), Erlangen, is using Isabellenhütte’s shunt-based management system IVT-S for precision current measurement in battery management systems in its foxBMS development platform.

The Isabellenhütte IVT series offers precise, temperature-compensated current and voltage measurement in a single component. Isabellenhütte's IVT systems are mainly used in the rapidly growing market for lithium-ion traction batteries and can be found in electric cars, electric trucks, electric buses and electric aircraft as well as in materials handling.

Fraunhofer IISB foxBMS – a gateway for researchers and developers
foxBMS is a research and development platform for battery management systems, which was developed by the Fraunhofer IISB based in Erlangen. foxBMS is an open-source platform, meaning that any companies or research institutes are free to use it to develop or test their own products – such as electric vehicles or applications with similar requirements.

Integrated system for precision measurements: IVT-S in the foxBMS
Fraunhofer IISB uses Isabellenhütte's IVT-S measurement system to achieve high-precision current measurements in the foxBMS platform. “We opted for the IVT-S from Isabellenhütte because this current sensor offers precision current measurement in combination with coulomb counting to determine state of charge in automotive battery systems up to 1,000 V,” explains Dr.-Ing. Vincent Lorentz, Group Manager Battery Systems at Fraunhofer IISB.

The IVT-S from Isabellenhütte has a galvanically isolated CAN interface. The integrated, three-channel HV sensor measures the voltage of the battery and monitors high-voltage protection and fuses.

The IVT-S is often used in the power distribution unit, the battery junction box or the HV box. This area is isolated from the battery cells and the BMS and often contains the circuit breaker on the plus/minus side of the battery and the pre-charging circuit required for traction batteries. The sensor is placed in the battery's minus pole, as the current measurement always takes place in relation to the voltage of the shunt ground. This enables the overall battery voltage to be monitored. In addition, voltage measurement can also be used to monitor the pre-charging circuit or the circuit breaker.

The IVT-S's integrated CAN bus interface ensures a reliable flow of data between the IVT-S and foxBMS. Due to the high level of precision and resolution in the mA range, the IVT-S also detects standby current and enables the foxBMS to record extremely precise information on the SoC (state of charge), SoH (state of health) and SoF (state of function) parameters of the overall battery system.
Besides raw data for current and voltage measurement, the BMS can also provide temperature, output and energy values through the CAN bus interface. The IVT-S also offers an ampere-hour meter for charging and discharging currents. The robust high-voltage box protects the IVT-S system from environmental stresses.

State-of-the-art measurement system
With 1 kV of permanent isolation voltage and a maximum peak voltage of 6 kV, Isabellenhütte is responding to the higher voltage ranges only made possible by lithium-ion technology. The IVT-S is a standard product now available in a dynamic market, offering state-of-the-art technology and meeting countless application-specific requirements.

Isabellenhütte Heusler GmbH & Co. KG is a leader in the field of shunt-based current measurement technology. Its precision measurement systems are marketed under the ISAscale® brand.

Isabellenhütte is a leading force in the area of precision alloys and also plays a pioneering role in low-ohm precision and high-performance resistors.

The company has been owned by the Heusler family since 1827. It currently employs some 850 people at the company headquarters in Dillenburg (Hesse). www.isabellenhuette.de

Company contact:
Isabellenhütte Heusler GmbH & Co. KG
Eibacher Weg 3-5
35683 Dillenburg, Germany

Tobias Wolff
Precision Measurement (VT-MT)
Area Sales Manager - DACH
Phone: +49 2771 934-258
Mobile: +49 170 7846265
Fax: +49 2771 934-99258
Tobias.Wolff@isabellenhuette.de

Jens Hartmann
Sales Director ISAscale
Phone: +49 (0)2771 / 934-250
Mobile: + 49 (0)170 / 779 0830
Fax: +49 2771 934-99258
Jens.Hartmann@isabellenhuette.de

Media:
Wassenberg Public Relations für
Industrie & Technologie GmbH
Rollnerstr. 43
90408 Nürnberg, Germany
Michaela Wassenberg
Tel.: +49 (0)911 / 598 398-0
Fax: +49 (0)911 / 598 398-18
m.wassenberg@wassenberg-pr.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Isabellenhüttes IVT-S measures current in the Fraunhofer development platform foxBMS here

News-ID: 684188 • Views:

More Releases from Isabellenhütte Heusler GmbH & Co. KG

Isabellenhütte meets high covid-19-related demand in record time
Isabellenhütte meets high covid-19-related demand in record time
Isabellenhütte, a specialist for precision alloys, supplies the alloy ISOTAN® as a heat conductor for ventilators. When demand for ventilators shot up as a result of the recent developments related to the coronavirus, Isabellenhütte put their rapid and reliable supply performance to the test. This is project organized by the federal government in which Isabellenhütte acts as a supplier to a reputable cable manufacturer. This cooperation had already been established for
Isabellenhütte receives type examination certification from PTB Braunschweig
Isabellenhütte receives type examination certification from PTB Braunschweig
As a specialist for shunt measurement technology, Isabellenhütte presents the first shunt-based, calibration law-compliant DC energy reference meter IEM-DCC-500 for charging infrastructure following the successful completion of the type examination. The DC meters are now available for purchase by manufacturers of charging stations and can be integrated into the designs of their applications. The basis of the type examination certification was the successfully conducted metrological measurement series (accuracy class B), the
New FMx shunt family: Small and low-ohmic
New FMx shunt family: Small and low-ohmic
Isabellenhütte has developed a new range of precision resistors in standard sizes with resistances ranging from 1 to 6 mOhm for applications which require small and low-ohmic shunts. In terms of their construction, the components are also less complex than the current ISA-PLAN®resistance families. And yet, they offer the same performance quality: very good long-term stability, a low temperature coefficient, and low thermoelectric voltages. With the FMx shunt family, Isabellenhütte has
BAX shunt: High-performance component for electric vehicles
BAX shunt: High-performance component for electric vehicles
Electromobility is steadily gaining ground in the automotive industry, and its relevance is increasing accordingly. With the presentation of its new BAX shunt, Isabellenhütte is now taking due account of the requirements that this trend is imposing on components for high-power battery management systems. In the last year, demand for high-performance shunts for use in electric vehicles has skyrocketed. This is down to the pace of development in the electromobility sector.

All 5 Releases


More Releases for IVT

Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview: The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections. Market Dynamics: Growing Prevalence of Cataracts: Cataracts, which are the primary cause of
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Hereditary retinal diseases is the major